Linezolid — a generic form of Pharmacia & Upjohn‘s brand name Zyvox injection — is intended to treat infections caused by susceptible Gram-positive bacteria.
The newly approved drug has an estimated market value of $87 million for the 12 months ending in June 2016.
India-based Aurobindo Pharma expects to launch the product by the end of the second quarter. The linezolid injection marks the drugmaker‘s 275th FDA approval.
More articles on the drug market:
AbbVie sues Amgen for patent infringement on Humira: 5 things to know
Bristol-Myers stock dips 18% following failed trial
Drug company drives $48k brain-eating amoeba treatment to SC hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
